Although basal activity was slightly lower than that of the WT promoter, this did not account for the loss of inducibility by NGF and EGF, suggesting that key DNA binding sites present in this region are essential for increasing promoter activity in breast cancer cells. This evidence concerns the gene EGF and breast carcinoma.